Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.

Oshima G, Poli EC, Bolt MJ, Chlenski A, Forde M, Jutzy JMS, Biyani N, Posner MC, Pitroda SP, Weichselbaum RR, Khodarev NN.

Cancer Res. 2019 Feb 1;79(3):650-662. doi: 10.1158/0008-5472.CAN-18-0692. Epub 2018 Dec 11.

PMID:
30538122
2.

STING promotes homeostasis via regulation of cell proliferation and chromosomal stability.

Ranoa DRE, Widau RC, Mallon S, Parekh AD, Nicolae CM, Huang X, Bolt MJ, Arina A, Parry R, Kron SJ, Moldovan GL, Khodarev NN, Weichselbaum RR.

Cancer Res. 2018 Nov 27. pii: canres.1972.2018. doi: 10.1158/0008-5472.CAN-18-1972. [Epub ahead of print]

PMID:
30482772
3.

Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Dhiman VK, Bolt MJ, White KP.

Nat Rev Genet. 2018 Mar;19(3):160-174. doi: 10.1038/nrg.2017.102. Epub 2017 Dec 27. Review.

PMID:
29279606
4.

High throughput microscopy identifies bisphenol AP, a bisphenol A analog, as a novel AR down-regulator.

Stossi F, Dandekar RD, Bolt MJ, Newberg JY, Mancini MG, Kaushik AK, Putluri V, Sreekumar A, Mancini MA.

Oncotarget. 2016 Mar 29;7(13):16962-74. doi: 10.18632/oncotarget.7655.

5.

Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.

Treviño LS, Bolt MJ, Grimm SL, Edwards DP, Mancini MA, Weigel NL.

Mol Endocrinol. 2016 Feb;30(2):158-72. doi: 10.1210/me.2015-1144. Epub 2015 Dec 11.

6.

Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays.

Stossi F, Bolt MJ, Ashcroft FJ, Lamerdin JE, Melnick JS, Powell RT, Dandekar RD, Mancini MG, Walker CL, Westwick JK, Mancini MA.

Chem Biol. 2014 Jun 19;21(6):743-53. doi: 10.1016/j.chembiol.2014.03.013. Epub 2014 May 22.

7.

Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity.

Bolt MJ, Stossi F, Callison AM, Mancini MG, Dandekar R, Mancini MA.

Oncogene. 2015 Jan 8;34(2):154-64. doi: 10.1038/onc.2013.550. Epub 2014 Jan 20.

8.

An extended posterior approach to the hip and pelvis for complex acetabular reconstruction that preserves the gluteal muscles and their neurovascular supply.

Solomon LB, Hofstaetter JG, Bolt MJ, Howie DW.

Bone Joint J. 2014 Jan;96-B(1):48-53. doi: 10.1302/0301-620X.96B1.31464.

PMID:
24395310
9.

Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses.

Bolt MJ, Stossi F, Newberg JY, Orjalo A, Johansson HE, Mancini MA.

Nucleic Acids Res. 2013 Apr;41(7):4036-48. doi: 10.1093/nar/gkt100. Epub 2013 Feb 26.

10.

Automated microscopy and image analysis for androgen receptor function.

Hartig SM, Newberg JY, Bolt MJ, Szafran AT, Marcelli M, Mancini MA.

Methods Mol Biol. 2011;776:313-31. doi: 10.1007/978-1-61779-243-4_18.

11.

Vitamin D receptor is required for dietary calcium-induced repression of calbindin-D9k expression in mice.

Bolt MJ, Cao LP, Kong J, Sitrin MD, Li YC.

J Nutr Biochem. 2005 May;16(5):286-90.

PMID:
15866228
12.

Critical role of vitamin D in sulfate homeostasis: regulation of the sodium-sulfate cotransporter by 1,25-dihydroxyvitamin D3.

Bolt MJ, Liu W, Qiao G, Kong J, Zheng W, Krausz T, Cs-Szabo G, Sitrin MD, Li YC.

Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E744-9. Epub 2004 May 27.

13.

Regulation of calbindin-D9k expression by 1,25-dihydroxyvitamin D(3) and parathyroid hormone in mouse primary renal tubular cells.

Cao LP, Bolt MJ, Wei M, Sitrin MD, Chun Li Y.

Arch Biochem Biophys. 2002 Apr 1;400(1):118-24.

PMID:
11913978
14.

Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism.

Li YC, Bolt MJ, Cao LP, Sitrin MD.

Am J Physiol Endocrinol Metab. 2001 Sep;281(3):E558-64.

15.

Single- and multifrequency models for bioelectrical impedance analysis of body water compartments.

Gudivaka R, Schoeller DA, Kushner RF, Bolt MJ.

J Appl Physiol (1985). 1999 Sep;87(3):1087-96.

16.

Rapid effects of 1,25(OH)2 vitamin D3 on signal transduction systems in colonic cells.

Sitrin MD, Bissonnette M, Bolt MJ, Wali R, Khare S, Scaglione-Sewell B, Skarosi S, Brasitus TA.

Steroids. 1999 Jan-Feb;64(1-2):137-42. Review.

PMID:
10323682
17.

Expression of G protein alpha subunits in normal rat colon and in azoxymethane-induced colonic neoplasms.

Bolt MJ, Mailloux RJ, Rasenick MM, Wali RK, Skarosi S, Bissonnette M, Brasitus TA, Sitrin MD.

Gastroenterology. 1998 Dec;115(6):1494-503.

PMID:
9834277
18.

1,25 dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation.

Khare S, Bolt MJ, Wali RK, Skarosi SF, Roy HK, Niedziela S, Scaglione-Sewell B, Aquino B, Abraham C, Sitrin MD, Brasitus TA, Bissonnette M.

J Clin Invest. 1997 Apr 15;99(8):1831-41.

19.

Guanylin activates rat colonic particulate guanylate cyclase.

Khare S, Wilson D, Wali RK, Tien XY, Bissonnette M, Niedziela SM, Bolt MJ, Sitrin MD, Brasitus TA.

Biochem Biophys Res Commun. 1994 Sep 30;203(3):1432-7.

PMID:
7945291
20.
21.

Characterization of phosphoinositide-specific phospholipase C in rat colonocyte membranes.

Bolt MJ, Bissonnette BM, Wali RK, Hartmann SC, Brasitus TA, Sitrin MD.

Biochem J. 1993 May 15;292 ( Pt 1):271-6.

22.

Differential effect of 1,25-dihydroxycholecalciferol on phosphoinositide turnover in the antipodal plasma membranes of colonic epithelial cells.

Wali RK, Bolt MJ, Tien XY, Brasitus TA, Sitrin MD.

Biochem Biophys Res Commun. 1992 Sep 16;187(2):1128-34.

PMID:
1326949
23.
24.

Effect of vitamin D status on the rapid actions of 1,25-dihydroxycholecalciferol in rat colonic membranes.

Wali RK, Baum CL, Sitrin MD, Bolt MJ, Dudeja PK, Brasitus TA.

Am J Physiol. 1992 Jun;262(6 Pt 1):G945-53.

PMID:
1352089
25.

Metabolism of 25-hydroxyvitamin D3 in rats: low-calcium diet vs. calcitriol infusion.

Bolt MJ, Jensen WE, Sitrin MD.

Am J Physiol. 1992 Mar;262(3 Pt 1):E359-67.

PMID:
1550228
26.
27.

Down-regulation of protein kinase C activity in 1,2-dimethylhydrazine-induced rat colonic tumors.

Wali RK, Baum CL, Bolt MJ, Dudeja PK, Sitrin MD, Brasitus TA.

Biochim Biophys Acta. 1991 Mar 19;1092(1):119-23.

PMID:
2009306
28.
29.

1,2-Dimethylhydrazine-induced alterations in protein kinase C activity in the rat preneoplastic colon.

Baum CL, Wali RK, Sitrin MD, Bolt MJ, Brasitus TA.

Cancer Res. 1990 Jul 1;50(13):3915-20.

30.

Serum unconjugated bile acids in patients with small bowel bacterial overgrowth.

Bolt MJ, Stellaard F, Sitrin MD, Paumgartner G.

Clin Chim Acta. 1989 Apr 28;181(1):87-101.

PMID:
2721008
31.

Dietary triacylglycerol modulates sodium-dependent D-glucose transport, fluidity and fatty acid composition of rat small intestinal brush-border membrane.

Brasitus TA, Dudeja PK, Bolt MJ, Sitrin MD, Baum C.

Biochim Biophys Acta. 1989 Feb 27;979(2):177-86.

PMID:
2923876
32.

24-Dehydrovitamin D is potent inhibitor of rat liver microsomal vitamin D-25-hydroxylase.

Bolt MJ, Holick SA, Holick MF, MacLaughlin J, Rosenberg IH.

Arch Biochem Biophys. 1988 Nov 1;266(2):532-8.

PMID:
2847656
33.
35.

Intestinal absorption of 1,25-dihydroxyvitamin D3 in the rat.

Sitrin MD, Pollack KL, Bolt MJ.

Am J Physiol. 1985 Jun;248(6 Pt 1):G718-25.

PMID:
3839110
36.

Hepatic vitamin D 25-hydroxylase inhibition by cimetidine and isoniazid.

Bengoa JM, Bolt MJ, Rosenberg IH.

J Lab Clin Med. 1984 Oct;104(4):546-52.

PMID:
6481217
37.

Altered bile acid physiology during lactation in the rat.

Bolt MJ, Lee TM, Moltz H.

Proc Soc Exp Biol Med. 1984 Jun;176(2):164-7.

PMID:
6718361
38.

Comparison of vitamin D and 25-hydroxyvitamin D absorption in the rat.

Sitrin MD, Pollack KL, Bolt MJ, Rosenberg IH.

Am J Physiol. 1982 Apr;242(4):G326-32.

PMID:
6978078
39.

Hepatic vitamin D 25-hydroxylase: inhibition by bile duct ligation or bile salts.

Bolt MJ, Sitrin MD, Favus MJ, Rosenberg IH.

Hepatology. 1981 Sep-Oct;1(5):436-40.

PMID:
6975744

Supplemental Content

Support Center